Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 2
1964 3
1965 1
1967 1
1972 1
1973 1
1975 2
1976 2
1977 9
1978 6
1979 8
1980 5
1981 2
1982 3
1983 11
1984 8
1985 4
1986 7
1987 5
1988 7
1989 5
1990 4
1991 4
1992 5
1993 3
1994 3
1995 3
1996 1
1997 1
1998 4
1999 5
2000 6
2001 15
2002 16
2003 15
2004 10
2005 8
2006 14
2007 14
2008 11
2009 9
2010 15
2011 17
2012 10
2013 26
2014 26
2015 16
2016 15
2017 34
2018 18
2019 22
2020 17
2021 18
2022 13
2023 10
2024 16
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Selenium status and type 2 diabetes risk.
Huang YC, Combs GF Jr, Wu TL, Zeng H, Cheng WH. Huang YC, et al. Among authors: wu tl. Arch Biochem Biophys. 2022 Nov 15;730:109400. doi: 10.1016/j.abb.2022.109400. Epub 2022 Sep 16. Arch Biochem Biophys. 2022. PMID: 36122760 Free PMC article. Review.
Spironolactone-digoxin interaction.
Hsieh YY, Lin MS, Chen JH, Hsu KL, Wu TL, Su CT, Shu MY, Hsu JC, Hsu WS, Chen JS. Hsieh YY, et al. Among authors: wu tl. Taiwan Yi Xue Hui Za Zhi. 1983 Jan;82(1):47-60. Taiwan Yi Xue Hui Za Zhi. 1983. PMID: 6575127 No abstract available.
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
Chen CB, Hsiao YH, Wu T, Hsih MS, Tassaneeyakul W, Jorns TP, Sukasem C, Hsu CN, Su SC, Chang WC, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Sun PL, Lee HE, Yang CY, Kao PH, Yang CH, Ho HC, Lin JY, Chang YC, Chen MJ, Lu CW, Ng CY, Kuo KL, Lin CY, Yang CS, Chen DP, Chang PY, Wu TL, Lin YJ, Weng YC, Kuo TT, Hung SI, Chung WH; Taiwan Severe Cutaneous Adverse Reaction Consortium. Chen CB, et al. Among authors: wu tl. Neurology. 2017 Jan 3;88(1):78-86. doi: 10.1212/WNL.0000000000003453. Epub 2016 Dec 2. Neurology. 2017. PMID: 27913699
Immune barriers to successful gene therapy.
Wu TL, Ertl HC. Wu TL, et al. Trends Mol Med. 2009 Jan;15(1):32-9. doi: 10.1016/j.molmed.2008.11.005. Epub 2008 Dec 26. Trends Mol Med. 2009. PMID: 19101205 Review.
Functional MRI and resting state connectivity in white matter - a mini-review.
Gore JC, Li M, Gao Y, Wu TL, Schilling KG, Huang Y, Mishra A, Newton AT, Rogers BP, Chen LM, Anderson AW, Ding Z. Gore JC, et al. Among authors: wu tl. Magn Reson Imaging. 2019 Nov;63:1-11. doi: 10.1016/j.mri.2019.07.017. Epub 2019 Jul 31. Magn Reson Imaging. 2019. PMID: 31376477 Free PMC article. Review.
Keck Foundation Biotechnology Resource Laboratory, Yale University.
Stone KL, Bjornson RD, Blasko GG, Bruce C, Cofrancesco R, Carriero NJ, Colangelo CM, Crawford JK, Crawford JM, daSilva NC, Deluca JD, Elliott JI, Elliott MM, Flory PJ, Folta-Stogniew EJ, Gulcicek E, Kong Y, Lam TT, Lee JY, Lin A, LoPresti MB, Mane SM, McMurray WJ, Tikhonova IR, Westman S, Williams NA, Wu TL, Hongyu Z, Williams KR. Stone KL, et al. Among authors: wu tl. Yale J Biol Med. 2007 Dec;80(4):195-211. Yale J Biol Med. 2007. PMID: 18449392 Free PMC article. Review. No abstract available.
Primary management of prostate cancer by universal health coverage effective coverage index.
Blas L, Shiota M, Onozawa M, Joung JY, Koo KC, Türkeri L, Şahin B, Lim J, Ong TA, Chiu PK, Ng CF, Wu TL, Le Chuyen V, Lojanapiwat B, Letran JL, Hakim L, Chiong E, Al-Edwan GM, Taguchi S, Yamamoto Y, Sakamoto S, Kawai T, Eto M, Nakagawa T, Hinotsu S, Kume H; Asian Prostate Cancer (A-CaP) study group. Blas L, et al. Among authors: wu tl. World J Urol. 2025 Mar 4;43(1):146. doi: 10.1007/s00345-025-05530-7. World J Urol. 2025. PMID: 40032670
490 results